Novonix (NVNXF) Non-Current Deffered Revenue (2021 - 2025)

Novonix has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $146475.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Deffered Revenue fell 95.12% year-over-year to $146475.0; the trailing twelve-month figure through Dec 2025 stood at $146475.0 (down 95.12% YoY), and the FY2025 full-year result was $146475.0, down 95.12% from the prior year.
• Non-Current Deffered Revenue for Q4 2025 stood at $146475.0, down from $3.5 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $3.5 million in Q2 2025, with the low at $146475.0 in Q4 2025.
• Historically, Non-Current Deffered Revenue has averaged $2.5 million across 5 years, with a median of $3.0 million in 2022.
• Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue jumped 1206.69% — and 2025, when it plunged 95.12%.
• Novonix's Non-Current Deffered Revenue stood at $3.0 million in 2021, then decreased by 0.31% to $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then sank by 95.12% to $146475.0 in 2025.
• The last three Non-Current Deffered Revenue figures came in at $146475.0 (Q4 2025), $3.5 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.